Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

April 27, 2017 by Alan Khadavi

AirDuo Respiclick, New Asthma Combo Maintenance Inhaler

airduo respiclick

AirDuo Respiclick is a new combination maintenance inhaler that will be available soon.  AirDuo Respiclick was recently FDA approved and it is indicated for the treatment of asthma in patients 12 years and older.  The ingredients in AirDuo Respiclick are the same as Advair, but in slightly different dosages.  The ingredients are; fluticasone propionate inhalation […]

Filed Under: Asthma, Blog

April 18, 2017 by Alan Khadavi

Chronic Sinusitis and Depression leads to lost productivity

gefapixant

Chronic sinusitis is an inflammatory diseases of the sinus mucosa that causes a significant decrease in quality of life.  The quality of life detriment is comparable or worse than other chronic diseases such as asthma and cardiac disease.  Chronic sinusitis has been associated with depression, decreased cognitive function, anxiety and diminished sleep.  Chronic sinusitis is […]

Filed Under: Blog, Sinus

April 5, 2017 by Alan Khadavi

Generic Advair Availability is Delayed

generic advair

Update January 30, 2019 The FDA just approved generic Advair and it should be available in the coming weeks. Mylan has not indicated the price on it yet but the hope is that it will be significantly cheaper than the branded version. It is anticipated that insurance companies will now require for patients to use […]

Filed Under: Asthma, Blog, Medications

March 29, 2017 by Alan Khadavi

Nemolizumab for Itching and Atopic Dermatitis

nemolizumab

Nemolizumab is a new medication being currently developed by Chugai Pharmaceutical Company.  It will be licensed and developed by Galderma Pharma who picked up the rights to it.  With the recent ground breaking FDA approval of Dupixent (dupilumab) for eczema, this will help many patients suffering itchy, inflamed dry skin.  As with all new biological […]

Filed Under: atopic dermatitis, Blog, Medications

March 22, 2017 by Alan Khadavi

Egg Allergy Prevention

egg allergy prevention

Preventing food allergies has been shown to be effective by an early introduction to foods rather than a delayed introduction.  The recent new of preventing peanut allergy. Peanut Allergy Prevention, has scientists looking into other foods as well.  Egg allergy prevention was recently investigated and published in the Lancet.  Researchers studied whether a stepwise early introduction of […]

Filed Under: Blog, Food allergy

March 12, 2017 by Alan Khadavi

Odactra Sublingual House Dust Mite Allergen Approved by FDA

odactra

Odactra the first sublingual house dust mite allergen, has been approved by the FDA.  Odactra will be administered under the tongue and it is used to treat house dust mite induced perennial allergic rhinitis and/or allergic conjunctivitis for adults 18-65 years of age. House dust mite is one of the most common perennial aeroallergens affecting […]

Filed Under: Allergy Medicine, Blog, Headlines

March 2, 2017 by Alan Khadavi

Spiriva Respimat for Add-on Asthma

spiriva respimat

Spiriva Respimat is an add on therapy for patients who have uncontrolled asthma.  It is approved for patients aged 12 and up who are already taking an inhaled corticosteroid or an inhaled corticosteroid plus a long acting beta-agonist, such as Advair, Dulera, Symbicort or Breo. Spiriva Respimat (tiotropium) can be used as add-on therapy for […]

Filed Under: Asthma, Blog

February 16, 2017 by Alan Khadavi

Xyzal OTC to be available March 2017

xyzal otc

Xyzal OTC will soon be available without a prescription March 2017.  In a growing trend in the allergy pharmaceutical market, most prescription medications are now becoming over the counter.  Xyzal (generic brand name is levoceterizine) received FDA approval earlier this month for treatment for the relief of symptoms of seasonal and year round allergies. The […]

Filed Under: Blog, Headlines, Medications

February 14, 2017 by Alan Khadavi

Coconut Allergy in Relation to Tree Nuts

coconut allergy

Many patients who have tree nut allergy wonder if they have coconut allergy as well.  That goes more to the question, is coconut a tree nut?  Coconut is actually a fruit, but the US FDA classifies coconut as a tree nut.  There has been little guidance in patients with tree nut allergies on the safety […]

Filed Under: Blog, Food allergy

February 9, 2017 by Alan Khadavi

New California Epinephrine Law for 2017

california epinephrine law

In 2017, a new California Epinephrine Law went into effect.  Businesses and public agencies in California are now defined as “authorized entities, are allowed to keep epinephrine auto injectors on hand to help treat emergency allergic reactions.”.  Liability and professional review protections remain in place for physicians issuing a prescription or order for epinephrine auto […]

Filed Under: Blog, Headlines

  • « Previous Page
  • 1
  • …
  • 37
  • 38
  • 39
  • 40
  • 41
  • …
  • 57
  • Next Page »

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page